EP Patent

EP1326854B1 — Chiral binaphthol derivatives

Assigned to Merck Patent GmbH · Expires 2004-06-23 · 22y expired

What this patent protects

The invention relates to chiral binaphthol derivatives of formula (I) wherein Y<1>, Y<2>, W<1> and W<2> have the meaning given in claim 1, to liquid crystalline mixtures comprising at least one chiral binaphthol derivative of formula (I), to chiral linear …

USPTO Abstract

The invention relates to chiral binaphthol derivatives of formula (I) wherein Y<1>, Y<2>, W<1> and W<2> have the meaning given in claim 1, to liquid crystalline mixtures comprising at least one chiral binaphthol derivative of formula (I), to chiral linear or crosslinked liquid crystalline polymers obtainable by polymerizing a polymerizable mixture comprising at least one chiral binaphthol derivative of formula (I), to the use of chiral binaphthol derivatives of formula (I) and mixtures and polymers obtained thereof in liquid crystal displays, active and passive optical elements, adhesives, synthetic resins with anisotropic mechanical properties, cosmetic and pharmaceutical compositions, diagnostics, liquid crystal pigments, for decorative and security applications, nonlinear optics, optical information storage or as chiral dopants, and to a liquid crystal display comprising a mixture comprising at least one chiral binaphthol derivative of formula (I).

Drugs covered by this patent

Patent Metadata

Patent number
EP1326854B1
Jurisdiction
EP
Classification
Expires
2004-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.